| Health / Medical Topics |
PR18 (ras-13 Cys) Peptide
A truncated synthetic form of the oncogene Ras, whose protein product p21 is located in the plasma membrane and transduces growth and differentiation signals from activated receptors to protein kinases within the cell. Because mutated Ras proteins may represent highly specific epitopes for T-cell recognition, PR18 (ras-13 Cys) peptide may be used in the vaccine immunotherapy of cancer. (NCI Thesaurus)
YOU MAY ALSO LIKE
A synthetic form of the ras peptide containing a point mutation at position 12 (glycine to cysteine). Vaccines using mutant ras peptides…
A cancer vaccine containing PR1, a 9 amino-acid human leukocyte antigen (HLA)-A2 restricted peptide derived from proteinase 3, with potential immunotherapeutic…
Describes cells that have a protein to which the hormone progesterone will bind. Cancer cells that are PR+ need progesterone to grow…
A synthetic form of the ras peptide containing a point mutation at position 12 (glycine to valine). Vaccines using mutant ras peptides…
A synthetic form of the ras peptide containing a point mutation at position 13 (glycine to asparagine). Vaccines using mutant ras peptides…
A tumor-specific peptide encoded by patient-specific mutant p53 oncogene with potential immunostimulatory properties. The peptide (LPTGQDL) contains a frame shift mutation at…
